ASO Visual Abstract: Survival Outcomes in Early-Onset Appendiceal Adenocarcinoma (EOAA).
ASO Visual Abstract: Survival Outcomes in Early-Onset Appendiceal Adenocarcinoma (EOAA). Ann Surg Oncol. 2026 Sep; 33(9):8565-8566.
PMID: 42289628
Guide Through the Fog: The Business of Oncology.
Guide Through the Fog: The Business of Oncology. JCO Oncol Pract. 2026 Aug; 22(8):1359-1362.
PMID: 42617337
Quadrivalvular Carcinoid Heart Disease Via Patent Foramen Ovale as Initial Presentation of Metastatic Neuroendocrine Tumor.
Quadrivalvular Carcinoid Heart Disease Via Patent Foramen Ovale as Initial Presentation of Metastatic Neuroendocrine Tumor. JACC Case Rep. 2026 Aug 19; 31(33):109223.
PMID: 42429734
Medicare and Oncology: The Long and Winding Road.
Medicare and Oncology: The Long and Winding Road. JCO Oncol Pract. 2026 Aug; 22(8):1380-1384.
PMID: 42258801
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA).
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA). Ann Surg Oncol. 2026 Sep; 33(9):8546-8554.
PMID: 42251206
340B Drug Pricing Program: An Updated ASCO Policy Statement.
340B Drug Pricing Program: An Updated ASCO Policy Statement. JCO Oncol Pract. 2026 Sep; 22(9):1490-1497.
PMID: 42085630
ASO Visual Abstract: Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma.
ASO Visual Abstract: Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2026 Apr; 33(4):3477-3478.
PMID: 41559464
Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma.
Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2026 Apr; 33(4):3453-3461.
PMID: 41634519
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. J Clin Oncol. 2026 Feb 20; 44(6):497-507.
PMID: 41499716
Evaluating the role of postoperative long-acting somatostatin analog therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking.
Evaluating the role of postoperative long-acting somatostatin analog therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking. Surgery. 2026 Jan; 189:109762.
PMID: 41073159